Pharmaceuticals

Biopharmaceuticals
Daily Rundown
Food Products
Pharmaceuticals
Retailers
Specialty Retailers
Stock Picks

The First Doses Of Pfizer & BioNTech’s COVID-19 Vaccine Administered In The U.S. Today

Plus, Bed Bath & Beyond is selling its Cost Plus World Market brand to a private equity firm, Virgin Galactic shares sink after it cut short its latest spaceflight, and fried chicken chain Popeyes is launching beignets.

Read More
Biopharmaceuticals
Daily Rundown
Digital Entertainment
Entertainment
Pharmaceuticals
Stock Picks
Streaming Media
Tech Stocks

The FDA Says It Is Working “Rapidly” To Clear Pfizer & BioNTech’s COVID-19 Vaccine

Plus, Disney shares surge higher following the announcement of a new slate of content for its Disney+ streaming service, and AMC raise $100 million but is still in danger of bankruptcy.

Read More
Biopharmaceuticals
Daily Rundown
Economic Trends
Economy
Facebook
IPO
Pharmaceuticals
Stock Picks
US Economy

Jobless Claims Rose To 853K As Congress Continues To Negotiate Another Round Of Stimulus

Plus, an FDA panel could vote to recommend approval of Pfizer and BioNTech’s coronavirus vaccine today, Facebook was hit with antitrust lawsuits from the FTC and 48 states and territories, and Airbnb priced its IPO above range.

Read More
Biopharmaceuticals
Daily Rundown
Earnings Reports
Economic Trends
Economy
IPO
Pharmaceuticals
Retailers
Specialty Retailers
Stock Picks
US Economy

Mnuchin Reignites Stimulus Hopes With $916 Billion Proposal

Plus, the U.S. surpassed 15 million coronavirus cases, Lowe’s said it expects sales to grow by 22% next year, and DoorDash sold 33 million shares at $102 a piece in its IPO.

Read More
Airlines
Apple
Biopharmaceuticals
Biotech
Daily Rundown
Electric Vehicles
Pharmaceuticals
Stock Picks
Tech Stocks

Stimulus Chances Are Dwindling As McConnell Rejects Bipartisan Plan

Plus, the FDA said Pfizer’s coronavirus vaccine was effective after just one dose, Tesla is having another share sale, and Apple announced the release of its Fitness+ subscription service.

Read More
Biopharmaceuticals
Biotech
Daily Rundown
IPO
Pharmaceuticals
Stock Picks
Tech Stocks

The U.K. Is About To Begin The First Public Doses Of Pfizer & BioNTech’s COVID-19 Vaccine

Plus, a bipartisan group is set to release more details of the $908 billion relief plan today, Cisco is buying London-based IMImobile, and Airbnb said it now expects to offer shares for its initial public offering at a range between $56 and $60 per share when it goes public on December 10.

Read More
Auto Industry
Biopharmaceuticals
Daily Rundown
Economic Trends
Economy
Pharmaceuticals
Stock Picks
Tech Stocks
Travel
US Economy

Salesforce Is Buying Slack For More Than $27 Billion

Plus, private payrolls grew at their slowest pace since July, the U.K. approved Pfizer and BioNTech’s coronavirus vaccine for emergency use, and Ford’s F-150 sales sank 20.9% last month.

Read More
Biopharmaceuticals
Defensive Stocks
Dividends
Fibonacci Retracement
Fundamental Analysis
Health
Health Insurance
HeathCare
Pharmaceuticals
Specialty Retailers
Technical Analysis
Vaccines
Value Investing
Value Stocks

CVS is a smart vaccine rollout investment

I hope everybody had a wonderful Thanksgiving holiday! I’ve written a lot in this space about my belief in defensive sectors and industries for more than a year now. The market is showing a lot of bullish momentum right now, but I think the initial relief that I attribute mostly to decreasing political uncertainty is […]

Read More
Biopharmaceuticals
Daily Rundown
Electric Vehicles
IPO
Pharmaceuticals
Retailers
S&P 500
Specialty Retailers
Stock Picks
Tech Stocks

Tesla Shares Rise As S&P Says Company Will Be Added To Index In One Piece

Plus, Pfizer and BioNTech applied for authorization of their coronavirus vaccine in Europe, Kohl’s announced it will be opening hundreds of Sephora stores in its existing stores, and Airbnb plans to price its IPO between $44 to $50 per share.

Read More
Athletic Apparel
Auto Industry
Biopharmaceuticals
Biotech
Bitcoin
Daily Rundown
Electric Power
Electric Vehicles
Pharmaceuticals
Retailers
Specialty Retailers
Stock Picks

Moderna To File For Emergency Authorization For Its COVID-19 Vaccine Today

Plus, Bitcoin hit a new all-time high, Under Armour announced a new deal with NBA star Steph Curry, and Nikola shares plummeted after GM pulled its equity stake in the electric car maker.

Read More
Biopharmaceuticals
Biotech
Fibonacci Retracement
Fundamental Analysis
Pharmaceuticals
Research
Technical Analysis
Vaccines
Value Investing
Value Stocks

GSK is a vaccine company you should pay attention to

Black Friday means that the market’s attention, along with most consumers is squarely focused on the retail segment. It is interesting to observe the way that retailers have adjusted their Black Friday operations around the limitations and uncertainty attached to the coronavirus pandemic. Those measures have not surprisingly pushed some of the conversation back in […]

Read More
Biopharmaceuticals
Fibonacci Retracement
Fundamental Analysis
Health
HeathCare
Medical
Pharmaceuticals
Technical Analysis
Value Investing
Value Stocks

Don’t ignore BMY – it’s still a big bargain

One of the most straightforward and useful ways for average investors like you and me to maintain an active investing approach without drowning in the massive volumes of news reports, analyst opinions and buzz around the thousands of publicly traded stocks is to work with our own watchlists. These are lists of stocks that you […]

Read More
Biopharmaceuticals
Daily Rundown
Donald Trump
Electric Vehicles
Federal Reserve
Marijuana
Pharmaceuticals
Pot Stocks
Stock Picks

Pfizer & BioNTech Will Apply For Emergency Use Authorization For Their COVID-19 Vaccine Today

Plus, the Treasury Department demanded the return of money the government provides to the Fed for lending to certain markets in times of stress, the U.S. set a new daily coronavirus case record, and Tesla hit a new all-time high.

Read More
Biotech
Fibonacci Retracement
Fundamental Analysis
Health
HeathCare
Pharmaceuticals
Research
Risk
Technical Analysis
Vaccines
Value Investing
Value Stocks

Should value investors bet on PFE’s COVID vaccine?

Post-election, a lot of the focus for the markets has, not surprisingly shifted back to COVID and the pandemic that just won’t stop. Concern is increasing that the colder months of the year will make things even worse, and that a health care system that is already being strained as infections and hospitalizations are pushing […]

Read More

Get Top Momentum Stocks with TradersPro

X